{"DataElement":{"publicId":"3595650","version":"1","preferredName":"Chronic Graft Versus Host Disease NIH Consensus Response Criteria Type","preferredDefinition":"Result of assessment of chronic Graft versus Host Disease (cGVHD) post treatment using the NIH Consensus Response criteria.","longName":"CGVHD_NIH_CON_RES_TP","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"3595640","version":"1","preferredName":"Chronic Graft Versus Host Disease NIH Consensus Response Criteria","preferredDefinition":"A disease or condition that persists or progresses over a long period of time._An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin._A tool to assess response to therapy in clinical trials for chronic Graft versus Host Disease (cGVHD).","longName":"2676585v1.0:3595638v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2676585","version":"1","preferredName":"Chronic Graft Versus Host Disease","preferredDefinition":"A disease or condition that persists or progresses over a long period of time.:An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.","longName":"C14141:C3063","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic","conceptCode":"C14141","definition":"Usually used to describe a condition that is persistent and long standing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3951A8C0-249F-64ED-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-04","endDate":null,"createdBy":"JOSHUAT","dateCreated":"2007-09-04","modifiedBy":"ONEDATA","dateModified":"2007-09-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3595638","version":"1","preferredName":"NIH Consensus Response Criteria for cGVHD","preferredDefinition":"A tool to assess response to therapy in clinical trials for chronic Graft versus Host Disease (cGVHD).","longName":"C103138","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NIH Consensus Response Criteria for Chronic GVHD","conceptCode":"C103138","definition":"A tool used to assess response to therapy for chronic Graft versus Host Disease (cGVHD) based on clinical trial findings and recommended by the NIH Chronic Graft-versus-Host Disease Consensus Response Criteria Working Group. The criteria were established in 2005 (Biol Blood Marrow Transplant, 12 (2006), pp. 252-266) and revised in 2014 (Biol Blood Marrow Transplant, 21 (2015), pp. 984-999).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA6AC159-597D-B7AA-E040-BB89AD430D21","latestVersionIndicator":"Yes","beginDate":"2012-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-23","modifiedBy":"ONEDATA","dateModified":"2012-09-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008563","version":"1","preferredName":"Therapy Results","preferredDefinition":"the results or effects (does not include CTC Adverse Events) of therapeutic agents or procedures administered to the patient.","longName":"TX_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6690D31-4081-494A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-06","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-11","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA6AC159-598E-B7AA-E040-BB89AD430D21","latestVersionIndicator":"Yes","beginDate":"2012-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-23","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3595642","version":"1","preferredName":"NIH Consensus Response Criteria for cGVHD Type","preferredDefinition":"A tool to assess response to therapy in clinical trials for chronic Graft versus Host Disease (cGVHD)._Something distinguishable as an identifiable class based on common qualities.","longName":"NIH_CGVHD_RESP_TP","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Mixed Response","valueDescription":"Mixed Response in cGVHD","ValueMeaning":{"publicId":"3595643","version":"1","preferredName":"Mixed Response in cGVHD","longName":"3595643","preferredDefinition":"Improvement in some organs, but worsening in others in chronic Graft versus Host Disease (cGVHD); this is categorized as progressive disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Response in cGVHD","conceptCode":"C103146","definition":"Improvement in some organs, but worsening in others in chronic Graft versus Host Disease (cGVHD); this is categorized as progressive disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA6AC159-59C8-B7AA-E040-BB89AD430D21","latestVersionIndicator":"Yes","beginDate":"2012-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CA6AC159-59E1-B7AA-E040-BB89AD430D21","beginDate":"2012-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-23","modifiedBy":"ONEDATA","dateModified":"2012-09-23","deletedIndicator":"No"},{"value":"Progressive Disease","valueDescription":"Progressive cGVHD","ValueMeaning":{"publicId":"3595644","version":"1","preferredName":"Progressive cGVHD","longName":"3595644","preferredDefinition":"Failure of therapy to control chronic Graft versus Host Disease (cGVHD).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progressive cGVHD","conceptCode":"C103145","definition":"Failure of therapy to control chronic Graft versus Host Disease (cGVHD).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA6AC159-59ED-B7AA-E040-BB89AD430D21","latestVersionIndicator":"Yes","beginDate":"2012-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CA6AC159-5A06-B7AA-E040-BB89AD430D21","beginDate":"2012-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-23","modifiedBy":"ONEDATA","dateModified":"2012-09-23","deletedIndicator":"No"},{"value":"Flare","valueDescription":"Exacerbation of cGVHD","ValueMeaning":{"publicId":"3595645","version":"1","preferredName":"Exacerbation of cGVHD","longName":"3595645","preferredDefinition":"A worsening of chronic Graft versus Host Disease (cGVHD) manifestations during withdrawal of immunosuppressive therapy which does not exceed those at the beginning of the trial and improves after reinstatement of previous treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Exacerbation of cGVHD","conceptCode":"C103143","definition":"A worsening of chronic Graft versus Host Disease (cGVHD) manifestations during withdrawal of immunosuppressive therapy which does not exceed those at the beginning of the trial and improves after reinstatement of previous treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA6AC159-5A12-B7AA-E040-BB89AD430D21","latestVersionIndicator":"Yes","beginDate":"2012-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CA6AC159-5A2B-B7AA-E040-BB89AD430D21","beginDate":"2012-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-23","modifiedBy":"ONEDATA","dateModified":"2012-09-23","deletedIndicator":"No"},{"value":"Stable Disease","valueDescription":"Stable cGVHD","ValueMeaning":{"publicId":"3595646","version":"1","preferredName":"Stable cGVHD","longName":"3595646","preferredDefinition":"No change in chronic Graft versus Host Disease (cGVHD)  progression during the preceding 3 months.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stable cGVHD","conceptCode":"C103142","definition":"No change in chronic Graft versus Host Disease (cGVHD) progression during the preceding 3 months.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA6AC159-5A37-B7AA-E040-BB89AD430D21","latestVersionIndicator":"Yes","beginDate":"2012-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CA6AC159-5A50-B7AA-E040-BB89AD430D21","beginDate":"2012-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-23","modifiedBy":"ONEDATA","dateModified":"2012-09-23","deletedIndicator":"No"},{"value":"Response < PR","valueDescription":"Less Than Partial Response in cGVHD","ValueMeaning":{"publicId":"3595647","version":"1","preferredName":"Less Than Partial Response in cGVHD","longName":"3595647","preferredDefinition":"Change towards improvement from the pretreatment baseline, but not meeting the criteria for Complete Response or Partial Response in chronic Graft versus Host Disease (cGVHD).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Less Than Partial Response in cGVHD","conceptCode":"C103141","definition":"Change towards improvement from the pretreatment baseline, but not meeting the criteria for Complete Response or Partial Response in chronic Graft versus Host Disease (cGVHD).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA6AC159-5A5C-B7AA-E040-BB89AD430D21","latestVersionIndicator":"Yes","beginDate":"2012-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CA6AC159-5A75-B7AA-E040-BB89AD430D21","beginDate":"2012-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-23","modifiedBy":"ONEDATA","dateModified":"2012-09-23","deletedIndicator":"No"},{"value":"PR","valueDescription":"Partial Response in cGVHD","ValueMeaning":{"publicId":"3595648","version":"1","preferredName":"Partial Response in cGVHD","longName":"3595648","preferredDefinition":"Improvement in one or more organ or tissue without progression in other affected organs or tissue in chronic Graft versus Host Disease (cGVHD).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Partial Response in cGVHD","conceptCode":"C103140","definition":"Improvement in one or more organ or tissue without progression in other affected organs or tissue in chronic Graft versus Host Disease (cGVHD).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA6AC159-5A81-B7AA-E040-BB89AD430D21","latestVersionIndicator":"Yes","beginDate":"2012-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CA6AC159-5A9A-B7AA-E040-BB89AD430D21","beginDate":"2012-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-23","modifiedBy":"ONEDATA","dateModified":"2012-09-23","deletedIndicator":"No"},{"value":"CR","valueDescription":"Complete Response in cGVHD","ValueMeaning":{"publicId":"3595649","version":"1","preferredName":"Complete Response in cGVHD","longName":"3595649","preferredDefinition":"Complete resolution of all signs and symptoms in all affected organs or tissues in chronic Graft versus Host Disease (cGVHD).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Response in cGVHD","conceptCode":"C103139","definition":"Complete resolution of all signs and symptoms in all affected organs or tissues in chronic Graft versus Host Disease (cGVHD).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA6AC159-5AA6-B7AA-E040-BB89AD430D21","latestVersionIndicator":"Yes","beginDate":"2012-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CA6AC159-5ABF-B7AA-E040-BB89AD430D21","beginDate":"2012-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-23","modifiedBy":"ONEDATA","dateModified":"2012-09-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008563","version":"1","preferredName":"Therapy Results","preferredDefinition":"the results or effects (does not include CTC Adverse Events) of therapeutic agents or procedures administered to the patient.","longName":"TX_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6690D31-4081-494A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-06","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-11","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3595641","version":"1","preferredName":"NIH Consensus Response Criteria for cGVHD Type","preferredDefinition":"A tool to assess response to therapy in clinical trials for chronic Graft versus Host Disease (cGVHD).:Something distinguishable as an identifiable class based on common qualities.","longName":"C103138:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NIH Consensus Response Criteria for Chronic GVHD","conceptCode":"C103138","definition":"A tool used to assess response to therapy for chronic Graft versus Host Disease (cGVHD) based on clinical trial findings and recommended by the NIH Chronic Graft-versus-Host Disease Consensus Response Criteria Working Group. The criteria were established in 2005 (Biol Blood Marrow Transplant, 12 (2006), pp. 252-266) and revised in 2014 (Biol Blood Marrow Transplant, 21 (2015), pp. 984-999).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA6AC159-59A2-B7AA-E040-BB89AD430D21","latestVersionIndicator":"Yes","beginDate":"2012-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-23","modifiedBy":"ONEDATA","dateModified":"2012-09-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA6AC159-59B3-B7AA-E040-BB89AD430D21","latestVersionIndicator":"Yes","beginDate":"2012-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-23","modifiedBy":"ONEDATA","dateModified":"2012-09-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"cGVHD Response","type":"Preferred Question Text","description":"cGVHD Response","url":null,"context":"CCR"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CA6AC159-5AC9-B7AA-E040-BB89AD430D21","latestVersionIndicator":"Yes","beginDate":"2012-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-23","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeDescription":"Curated to support NCI CCR Transplanation trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}